• Explore /
  • Poster
  • / Impact of corticosteroid (CS) exposure on acquired resistance to immune checkpoint inhibitor (ICI) therapy in patients (pts) with metastatic renal cell carcinoma (mRCC): A single centre experience.

Impact of corticosteroid (CS) exposure on acquired resistance to immune checkpoint inhibitor (ICI) therapy in patients (pts) with metastatic renal cell carcinoma (mRCC): A single centre experience.

Abstract Poster

Authors

null

Sowmya Cheruvu

The Royal Marsden Hospital, London, United Kingdom

Sowmya Cheruvu , Laura Marandino , Ana Gutierrez , Ha Mo Linh Le , Carlo Andrea Bravi , Diana I. Rosero , Nalinie Joharatnam Hogan , David Mcmahon , Walter Cazzaniga , James Larkin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 404)

DOI

10.1200/JCO.2024.42.4_suppl.404

Abstract #

404

Poster Bd #

G7

Abstract Disclosures

Similar Posters

First Author: Connor Wells

First Author: Ana-Alicia Beltran-Bless

First Author: Audreylie Lemelin

Poster

2022 ASCO Genitourinary Cancers Symposium

Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).

Characterizing IMDC prognostic groups in contemporary first-line combination therapies for metastatic renal cell carcinoma (mRCC).

First Author: Matthew Scott Ernst